Who are Alprostadil 20 micrograms's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Cytotec, low dose peroral misoprostol, Lipo-PGE1, Misoprostol 400 Microgram Oral Tablet, Alprostadil ﹠control, preoperative vaginal misoprostol.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/alprostadil-20-micrograms.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Alprostadil 20 micrograms — Competitive Intelligence Brief

Alprostadil 20 micrograms (Alprostadil 20 micrograms) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Prostaglandin E1 analog. Area: Cardiovascular.

phase 2 Prostaglandin E1 analog Prostanoid receptors (EP receptors) Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Alprostadil 20 micrograms (Alprostadil 20 micrograms) — Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. Alprostadil is a prostaglandin E1 analog that vasodilates blood vessels and inhibits platelet aggregation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Alprostadil 20 micrograms TARGET	Alprostadil 20 micrograms	Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia	phase 2	Prostaglandin E1 analog	Prostanoid receptors (EP receptors)
Cytotec	misoprostol	Generic (originally Searle/Pfizer)	marketed	Prostaglandin E1 analog	Prostaglandin E2 receptor EP2 subtype, Prostaglandin E2 receptor EP3 subtype, Prostaglandin E2 receptor EP4 subtype	1988-12-27
low dose peroral misoprostol	low dose peroral misoprostol	University Medical Centre Ljubljana	marketed	Prostaglandin E1 analogue	Prostaglandin E receptor (EP receptor)
Lipo-PGE1	Lipo-PGE1	West China Hospital	marketed	Prostaglandin E1 analog	Prostaglandin E receptor (EP receptors)
Misoprostol 400 Microgram Oral Tablet	Misoprostol 400 Microgram Oral Tablet	Assuta Ashdod Hospital	marketed	Prostaglandin E1 analogue	Prostaglandin E receptor (EP receptor)
Alprostadil ﹠control	Alprostadil ﹠control	Shanghai 10th People's Hospital	marketed	Prostaglandin E1 analog	Prostanoid receptors (EP receptors)
preoperative vaginal misoprostol	preoperative vaginal misoprostol	Ain Shams Maternity Hospital	marketed	Prostaglandin E1 analogue	Prostaglandin E receptor (EP receptor)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Prostaglandin E1 analog class)

Dong-A ST Co., Ltd. · 1 drug in this class
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · 1 drug in this class
Generic (originally Searle/Pfizer) · 1 drug in this class
Shanghai 10th People's Hospital · 1 drug in this class
West China Hospital · 1 drug in this class
Wolfson Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Alprostadil 20 micrograms — Competitive Intelligence Brief. https://druglandscape.com/ci/alprostadil-20-micrograms. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab